Mark C Wilkes

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

C. Daniels, A. Limper, S. Murphy, 2004, The Journal of clinical investigation.

The FASEB Journal • Research Communication Imatinib mesylate blocks a non-Smad TGF- � pathway and reduces renal fibrogenesis in vivo

E. Leof, Mark C Wilkes, Edward B Leof, 2022 .

Transforming Growth Factor-B Activation of Phosphatidylinositol 3-Kinase Is Independent of Smad 2 and Smad 3 and Regulates Fibroblast Responses via p 21-Activated Kinase-2

J. Doré, Kaori Suzuki, R. Pagano, 2005 .